Kiniksa Pharmaceuticals International (KNSA) Profit After Tax: 2021-2025
Historic Profit After Tax for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $18.4 million.
- Kiniksa Pharmaceuticals International's Profit After Tax rose 245.24% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year increase of 496.10%. This contributed to the annual value of -$43.2 million for FY2024, which is 406.68% down from last year.
- Latest data reveals that Kiniksa Pharmaceuticals International reported Profit After Tax of $18.4 million as of Q3 2025, which was up 3.38% from $17.8 million recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Profit After Tax ranged from a high of $224.1 million in Q3 2022 and a low of -$49.5 million during Q1 2021.
- Its 3-year average for Profit After Tax is $1.4 million, with a median of -$3.9 million in 2024.
- Per our database at Business Quant, Kiniksa Pharmaceuticals International's Profit After Tax soared by 833.67% in 2022 and then crashed by 135.22% in 2024.
- Quarterly analysis of 5 years shows Kiniksa Pharmaceuticals International's Profit After Tax stood at -$36.3 million in 2021, then skyrocketed by 112.28% to $4.5 million in 2022, then skyrocketed by 465.73% to $25.2 million in 2023, then crashed by 135.22% to -$8.9 million in 2024, then spiked by 245.24% to $18.4 million in 2025.
- Its Profit After Tax was $18.4 million in Q3 2025, compared to $17.8 million in Q2 2025 and $8.5 million in Q1 2025.